| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 953 | 2.120 | 2.211 | 9.389 | 12.590 | 12.670 | 13.901 |
| Total Income - EUR | - | - | - | 953 | 2.120 | 2.211 | 9.389 | 12.590 | 12.670 | 13.901 |
| Total Expenses - EUR | - | - | - | 280 | 960 | 1.000 | 810 | 1.558 | 2.045 | 6.248 |
| Gross Profit/Loss - EUR | - | - | - | 673 | 1.160 | 1.211 | 8.579 | 11.032 | 10.624 | 7.653 |
| Net Profit/Loss - EUR | - | - | - | 644 | 1.096 | 1.146 | 8.297 | 10.711 | 8.915 | 6.197 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alercare Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 30.750 |
| Current Assets | - | - | - | 706 | 2.013 | 1.394 | 8.479 | 11.755 | 10.416 | 6.036 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 1.002 | 478 | 4.631 | 5.671 |
| Cash | - | - | - | 706 | 2.013 | 1.394 | 7.478 | 11.277 | 5.785 | 366 |
| Shareholders Funds | - | - | - | 687 | 1.770 | 1.359 | 8.362 | 11.629 | 10.000 | 6.250 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 19 | 243 | 35 | 117 | 127 | 416 | 30.536 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alercare Med S.r.l.